AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 06/05/23

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $44.97 million
NAV $27.76
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 06/02/23

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 1,620,000
Number of Holdings 94
30-Day Median Bid-Ask Spread 0.33%

Distributions As of 06/05/23

30-Day SEC Yield 0.93%
Distribution Frequency Semi-Annually

ETF Prices As of 06/05/23

NAV $27.76 Daily Change $0.10 0.36%
Market Price $27.69 Daily Change $0.00 0.00%

Performance History

As of recent
(03/31/23)
As of recent
(03/31/23)
Fund NAV Market Price Index
1 Year -5.77% -6.05% -5.58%
3 Years 10.49% 10.40% 10.73%
5 Years 7.13% 6.99% 7.35%
Since Inception 9.37% 9.65% 9.64%
1 Year 4.62% 4.03% 4.85%
3 Years 4.51% 4.38% 4.73%
5 Years 6.72% 6.60% 6.93%
Since Inception 9.32% 9.60% 9.59%
Year-to-Date 2.40% 2.29% 2.45%
1 Month 2.44% 2.33% 2.44%
3 Months 2.40% 2.29% 2.45%
Since Inception 85.42% 88.76% 88.63%
Year-to-Date 3.62% 3.55% 3.71%
1 Month -3.72% -3.80% -3.69%
3 Months 3.66% 3.59% 3.70%
Since Inception 87.62% 91.08% 90.95%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 06/05/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.65 LLY ELI LILLY & CO 2516152 444.26 3,696 1,641,984.96
3.41 4519 JP CHUGAI PHARMA CO 6196408 28.09 54,630 1,534,592.32
3.37 ALC SW ALCON INC BJT1GR5 79.33 19,122 1,516,932.53
3.25 DXCM DEXCOM INC B0796X4 124.66 11,715 1,460,391.90
3.19 BIIB BIOGEN INC 2455965 302.13 4,747 1,434,211.11
3.14 MDT MEDTRONIC PLC BTN1Y11 83.73 16,851 1,410,934.23
3.12 WELL WELLTOWER INC BYVYHH4 76.09 18,441 1,403,175.69
3.08 EW EDWARDS LIFESCIENCES CORP 2567116 85.94 16,108 1,384,321.52
3.03 BSX BOSTON SCIENTIFIC CORP 2113434 51.40 26,507 1,362,459.80
2.97 AZN ASTRAZENECA PLC-SPONS ADR 2989044 73.20 18,254 1,336,192.80
2.89 SYK STRYKER CORP 2853688 277.96 4,679 1,300,574.84
2.89 JNJ JOHNSON & JOHNSON 2475833 158.32 8,207 1,299,332.24
2.87 SGEN SEAGEN INC BLPK4D2 195.19 6,615 1,291,181.85
2.85 NOVOB DC NOVO NORDISK A/S-B BHC8X90 155.46 8,245 1,281,796.68
2.84 BMY BRISTOL-MYERS SQUIBB CO 2126335 65.98 19,361 1,277,438.78
2.78 REGN REGENERON PHARMACEUTICALS 2730190 750.27 1,666 1,249,949.82
2.67 AMGN AMGEN INC 2023607 221.88 5,401 1,198,373.88
2.59 RO SW ROCHE HOLDING AG-BR 7108918 344.68 3,379 1,164,671.04
2.55 ABBV ABBVIE INC B92SR70 136.86 8,385 1,147,571.10
2.09 4503 JP ASTELLAS PHARMA INC 6985383 16.38 57,458 941,141.92
1.94 ZBH ZIMMER BIOMET HO 2783815 130.47 6,689 872,713.83
1.81 GMAB DC GENMAB A/S 4595739 391.46 2,084 815,809.24
1.69 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 149.56 5,074 758,846.69
1.69 4543 JP TERUMO CORP 6885074 31.82 23,834 758,428.24
1.62 BGNE BEIGENE LTD-ADR BYYWPW6 221.84 3,284 728,522.56
1.38 PODD INSULET CORP B1XGNW4 284.07 2,184 620,408.88
1.36 068270 KS CELLTRION INC B0C5YV1 131.64 4,642 611,039.82
1.26 VTR VENTAS INC 2927925 44.66 12,663 565,529.58
1.22 UCB BB UCB SA 5596991 88.73 6,161 546,688.28
1.12 SOON SW SONOVA HOLDING AG-REG 7156036 259.39 1,938 502,701.83
1.07 EXAS EXACT SCIENCES CORP 2719951 84.95 5,651 480,052.45
0.98 INCY INCYTE CORP 2471950 62.37 7,060 440,332.20
0.94 SN/ LN SMITH & NEPHEW PLC 0922320 15.18 27,731 420,870.57
0.91 FME GR FRESENIUS MEDICA 5129074 43.81 9,309 407,825.90
0.81 TFX TELEFLEX INC 2881407 240.67 1,504 361,967.68
0.77 COH AU COCHLEAR LTD 6211798 164.33 2,096 344,433.34
0.72 UTHR UNITED THERAPEUTICS CORP 2430412 218.88 1,474 322,629.12
0.69 3692 HK HANSOH PHARMACEU BJYKB72 1.69 184,243 311,256.23
0.65 DEMANT DC DEMANT A/S BZ01RF1 38.82 7,515 291,698.81
0.64 NBIX NEUROCRINE BIOSC 2623911 93.86 3,059 287,117.74
0.63 DVA DAVITA INC 2898087 99.16 2,845 282,110.20
0.61 NVCR NOVOCURE LTD BYSS4X4 82.51 3,316 273,603.16
0.60 AGL AGILON HEALTH INC BLR4TK4 20.71 13,103 271,363.13
0.59 AMP IM AMPLIFON SPA B14NJ71 36.37 7,302 265,540.07
0.49 OHI OMEGA HEALTHCARE 2043274 29.81 7,361 219,431.41
0.44 EXEL EXELIXIS INC 2576941 19.48 10,224 199,163.52
0.39 ACAD ACADIA PHARMACEU 2713317 23.97 7,298 174,933.06
0.39 GKOS GLAUKOS CORP BYMWL19 62.61 2,763 172,991.43
0.37 DNLI DENALI THERAPEUTICS INC BD2B4V0 30.46 5,489 167,194.94
0.37 ENSG ENSIGN GROUP INC/THE B1YWPP8 91.55 1,807 165,430.85
0.36 BPMC BLUEPRINT MEDICINES CORP BWY52P3 56.02 2,887 161,729.74
0.35 145720 KS DENTIUM CO LTD BF07GJ6 130.03 1,222 158,897.83
0.35 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 26.06 6,059 157,897.54
0.34 MMSI MERIT MEDICAL SYSTEMS INC 2580555 83.95 1,827 153,376.65
0.34 AMED AMEDISYS INC 2024332 91.74 1,668 153,022.32
0.34 GN DC GN STORE NORD A/S 4501093 26.10 5,834 152,239.09
0.34 RYM NZ RYMAN HEALTHCARE LTD 6161525 3.79 39,974 151,675.89
0.33 ALEC ALECTOR INC BJ4LDC4 7.19 20,580 147,970.20
0.33 LIVN LIVANOVA PLC BYMT0J1 46.34 3,168 146,805.12
0.32 CSH-U CN CHARTWELL RETIRE B8S8C94 6.85 21,187 145,236.33
0.32 NHC NATIONAL HEALTHCARE CORP 2139731 61.40 2,360 144,904.00
0.32 ANGO ANGIODYNAMICS INC B00CR04 10.00 14,408 144,080.00
0.32 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 8.61 16,631 143,218.09
0.31 NHI NATL HEALTH INVESTORS INC 2626125 52.77 2,674 141,106.98
0.31 HALO HALOZYME THERAPEUTICS INC 2975098 33.06 4,267 141,067.02
0.31 MNKD MANNKIND CORP BF081J4 4.32 32,534 140,546.88
0.31 CANO CANO HEALTH INC BN0WWW2 1.46 96,090 140,291.40
0.31 ITGR INTEGER HOLDINGS CORP BD06LM7 82.65 1,685 139,265.25
0.31 KORI FP KORIAN B1HKRM0 7.93 17,369 137,674.97
0.30 8086 JP NIPRO CORP 6641599 7.32 18,378 134,556.62
0.29 ATEC ALPHATEC HOLDINGS INC BD60BG7 15.39 8,592 132,230.88
0.29 SBRA SABRA HEALTH CAR B5NLBP6 11.48 11,511 132,146.28
0.29 FGEN FIBROGEN INC BSDRYR8 19.19 6,885 132,123.15
0.29 DCPH DECIPHERA PHARMA BZ1LFB2 14.42 9,067 130,746.14
0.28 TBPH THERAVANCE BIOPHARMA INC BMNDK09 11.14 11,374 126,706.36
0.28 LTC LTC PROPERTIES INC 2498788 32.58 3,876 126,280.08
0.28 9229 JP SUNWELS CO LTD BNTYNB5 23.20 5,423 125,813.76
0.28 EKTAB SS ELEKTA AB-B SHS B0M42T2 7.63 16,442 125,456.89
0.28 EMBC EMBECTA CORP BMXWYR1 26.21 4,730 123,973.30
0.27 NUVA NUVASIVE INC B00GJC2 38.97 3,164 123,301.08
0.27 AED BB AEDIFICA B1G5XP1 70.53 1,692 119,345.10
0.27 AMRN AMARIN CORP PLC -ADR 2301938 1.24 96,194 119,280.56
0.26 6600 HK SCICLONE PHARMAC BMX5ZW2 1.30 89,600 116,384.42
0.26 BKD BROOKDALE SR B0PZN33 3.54 32,596 115,389.84
0.25 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.42 263,024 111,758.02
0.24 SGHT SIGHT SCIENCES INC BN2T5Q6 7.48 14,634 109,462.32
0.23 PHM SM PHARMA MAR SA BMW2GT8 36.01 2,920 105,154.78
0.23 1858 HK BEIJING CHUNLI-H BVVPXP6 1.98 51,516 101,885.62
0.22 SILK SILK ROAD MEDICAL INC BGHVXJ7 29.76 3,375 100,440.00
0.22 853 HK MICROPORT SCIENTIFIC CORP B676TW7 1.80 54,902 98,914.95
0.22 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.29 332,592 97,606.49
0.21 CASH 1.00 93,952 93,951.60
0.21 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.90 103,989 93,411.24
0.20 2500 HK VENUS MEDTECH -H BL6V047 0.98 91,440 89,605.88
0.01 EURO 1.07 4,981 5,335.62
0.00 BRITISH STERLING POUND 1.17 0 0.07
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.00
0.00 JAPANESE YEN 0.01 -2 -0.01
0.00 SWISS FRANC 1.00 0 -0.02
0.00 AUSTRALIAN DOLLAR 0.69 0 -0.09
Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 04/30/23

Sector Weight (%)
Health Care 93.9
Real Estate 6.1

Source: AltaVista Research, LLC

Country Breakdown As of 04/30/23

Country Weight (%)
United States 58.1
Switzerland 8.6
Japan 7.1
Denmark 6.0
Britain 4.7
China 4.6
Ireland 3.6
Belgium 1.6
South Korea 1.5
Germany 1.0
Australia 0.7
Other/Cash 2.5

Source: AltaVista Research, LLC

ETF Characteristics As of 06/02/23

Return on Equity 12.50%
Weighted Avg. Market Cap 69,970 M
2022 2023
Price-to-earnings 26.64 27.64
Price-to-book value 3.57 3.33

Source: AltaVista Research, LLC

ETF Risk Stats As of 05/31/23

Versus Beta
S&P 500 0.65
NASDAQ-100 0.44
MSCI EAFE 0.68
MSCI Emg. Mkts 0.46
Standard Deviation 15.60%

Source: AltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Back to Top